Form 4: BioAtla CMO's Tax-Related Share Withholding

BioAtla's Chief Medical Officer, Eric Sievers, had 2,729 shares withheld by the company to cover tax obligations related to restricted stock unit vesting.

Summary

• Eric Sievers, Chief Medical Officer of BioAtla, Inc. (BCAB), reported a transaction on August 31, 2025.
• The transaction involved the disposition of 2,729 shares of BioAtla Common Stock at a price of $0.4555 per share.
• This disposition was not a sale by Mr. Sievers but rather shares withheld by BioAtla to satisfy income tax and withholding obligations upon the vesting and net settlement of previously reported restricted stock units.
• Following this transaction, Mr. Sievers directly beneficially owns 364,574 shares of Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine administrative transaction where shares were withheld for tax purposes upon RSU vesting, which is a neutral event regarding company performance or strategy.

Positives

• Vesting of restricted stock units (RSUs) for the Chief Medical Officer indicates continued compensation and retention of key management.

Negatives

• A reduction of 2,729 shares in direct beneficial ownership by the Chief Medical Officer, though for tax purposes, represents a technical disposition.

Future Outlook

NA

Management Comments

• The reported transaction is not a sale of shares by the Reporting Person but represents shares withheld by the Issuer to satisfy income tax and withholding obligations in connection with the vesting and net settlement of previously reported restricted stock units.

Industry Context

This is a routine insider transaction for tax purposes, common across industries for executives receiving equity compensation. It does not provide specific insights into broader industry trends.

Comparison to Industry Standards

• The withholding of shares for tax obligations upon the vesting of restricted stock units is a standard practice for executive equity compensation across publicly traded companies, aligning with typical industry compensation structures.

Related Party Transactions

• The withholding of shares by BioAtla from its Chief Medical Officer for tax obligations related to RSU vesting is a standard related-party transaction for executive compensation.

Stakeholder Impact

• Shareholders: Indicates routine executive compensation and retention through equity vesting.
• Employees: Reflects standard equity compensation practices for executives.

Key Dates

Recommendation

This Form 4 filing details a routine administrative transaction where shares were withheld for tax purposes upon the vesting of restricted stock units for a company executive. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is maintained, pending further substantive corporate announcements.

Keywords

BioAtla, BCAB, Eric Sievers, Chief Medical Officer, Form 4, insider transaction, stock withholding, restricted stock units, RSU vesting